Multiple sclerosis (MS) is typically characterised by hyperintense T2 white matter lesions. However, the quantity and location of these may not correlate to a patient’s functional state or impending disease progression. Quantitative susceptibility mapping (QSM) is an emerging biomarker associated with tissue iron concentration and regions of demyelination in white matter. This pilot study examined both clinical and MRI parameter relationships to the QSM value over a number of brain regions in patients with mild (EDSS =or<2) relapsing and remitting MS.
This abstract and the presentation materials are available to members only; a login is required.